(Q41130119)

27 September 2017

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution (English)

1 reference

27 September 2017

7

1 reference

27 September 2017

Anne-Lise Børresen-Dale

series ordinal

6

object named as

Anne-Lise Børresen-Dale

1 reference

27 September 2017

5

Therese Sørlie

1 reference

27 September 2017

8

Anita Langerød

1 reference

27 September 2017

Aslaug Aamodt Muggerud

series ordinal

2

object named as

Aslaug A Muggerud

1 reference

27 September 2017

4

Eldri U Due

1 reference

27 September 2017

Wenjing Zhou

1

1 reference

27 September 2017

Phuong Vu

series ordinal

3

1 reference

27 September 2017

language of work or name

1 reference

2 April 2009

1 reference

27 September 2017

1 reference

27 September 2017

3

1 reference

27 September 2017

3

1 reference

27 September 2017

214-219

1 reference

Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

p53 in health and disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Gene expression profiles of human breast cancer progression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

27 September 2017

TP53 and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Breast carcinoma in situ: risk factors and screening patterns

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Histological and biological evolution of human premalignant breast disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Regulation of the p53 tumor suppressor protein

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

p53 and human cancer: the first ten thousand mutations.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

27 September 2017

p53: puzzle and paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Method for grading breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Ductal carcinoma in situ: a proposal for a new classification

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

The p53 tumour suppressor gene

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Patterns of chromosomal alterations in breast ductal carcinoma in situ

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Hormone dependence in premalignant mammary progression.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5527861

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

19 August 2018

1 reference

12 December 2020

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

12 December 2020

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast

1 reference

12 December 2020

p53 in Mammary ductal carcinoma in situ, mutations in high-grade lesions only?

1 reference

12 December 2020

The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer

1 reference

12 December 2020

Is breast tumor progression really linear?

1 reference

12 December 2020

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

1 reference

12 December 2020

10.1016/J.MOLONC.2009.03.001

Identifiers

DOI

1 reference

release_aseh45mlcngznmei5zfv4v6icm

27 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aseh45mlcngznmei5zfv4v6icm

24 November 2022

mapped directly with Wikidata item

1 reference

27 September 2017

PubMed publication ID

19403344

1 reference